Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease

doi:10.4239/wjd.v5.i2.115

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9953)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series.

Item

Count

PDF

503

WORD

383

HTML

6296

Figures (1-8)

649

Sum=7831

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1124

Download

997

Sum=2121

Apr 15, 2014 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Diabetes. Apr 15, 2014; 5(2): 115-127
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.115

Full Size Figure Download Figure

Figure 4 Correlation of baseline (aspirin-free) urinary 11-dehydro-thromboxane B₂ levels (pg/mg) measured in healthy individuals and diabetes patients with age (left), and disease duration of diabetes patients (right). Red lines: Linear regression fit.

Citation: Lopez LR, Guyer KE, Torre IGDL, Pitts KR, Matsuura E, Ames PR. Platelet thromboxane (11-dehydro-Thromboxane B₂) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes 2014; 5(2): 115-127
URL: https://www.wjgnet.com/1948-9358/full/v5/i2/115.htm
DOI: https://dx.doi.org/10.4239/wjd.v5.i2.115